Hjem › Crohns sygdom › Wisconsin
Crohns sygdom kliniske forsøg i Wisconsin
7 studier for Crohns sygdom søger deltagere på steder i Wisconsin.
Byer i Wisconsin
Officiel studietekst (engelsk)
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Wisconsin Center for Advanced Research, Milwaukee
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Froedtert Hospital and the Medical College of Wisconsin-Site Number: 8400081, Milwaukee
RekruttererFase 3
Alder 16 til 80 · Alle køn · Opdateret 23. sep. 2026 · NCT07184931Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Medical College of Wisconsin, Milwaukee
RekruttererFase 4
Alder 6 til 17 · Alle køn · Opdateret 27. maj 2026 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Medical College of Wisconsin Cancer Center - Froedtert Hospital, Milwaukee
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 27. maj 2026 · NCT06227910Precise Infliximab Exposure and Pharmacodynamic Control
- Medical College of Wisconsin, Children's of Wisconsin, Milwaukee
RekruttererFase 2/3
Alder 6 til 22 · Alle køn · Opdateret 5. maj 2026 · NCT05660746A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Milwaukee
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Brain Inflammation Collaborative, Delafield
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 og opefter · Alle køn · Opdateret 22. jan. 2026 · NCT04806620Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.